183 related articles for article (PubMed ID: 30519791)
1. Centiloid scaling for quantification of brain amyloid with [
Battle MR; Pillay LC; Lowe VJ; Knopman D; Kemp B; Rowe CC; Doré V; Villemagne VL; Buckley CJ
EJNMMI Res; 2018 Dec; 8(1):107. PubMed ID: 30519791
[TBL] [Abstract][Full Text] [Related]
2. Standardized Expression of 18F-NAV4694 and 11C-PiB β-Amyloid PET Results with the Centiloid Scale.
Rowe CC; Jones G; Doré V; Pejoska S; Margison L; Mulligan RS; Chan JG; Young K; Villemagne VL
J Nucl Med; 2016 Aug; 57(8):1233-7. PubMed ID: 26912446
[TBL] [Abstract][Full Text] [Related]
3. Comparison of qualitative and quantitative imaging characteristics of [11C]PiB and [18F]flutemetamol in normal control and Alzheimer's subjects.
Mountz JM; Laymon CM; Cohen AD; Zhang Z; Price JC; Boudhar S; McDade E; Aizenstein HJ; Klunk WE; Mathis CA
Neuroimage Clin; 2015; 9():592-8. PubMed ID: 26640770
[TBL] [Abstract][Full Text] [Related]
4.
Rowe CC; Doré V; Jones G; Baxendale D; Mulligan RS; Bullich S; Stephens AW; De Santi S; Masters CL; Dinkelborg L; Villemagne VL
Eur J Nucl Med Mol Imaging; 2017 Nov; 44(12):2053-2059. PubMed ID: 28643043
[TBL] [Abstract][Full Text] [Related]
5. Implementing the centiloid transformation for
Bourgeat P; Doré V; Fripp J; Ames D; Masters CL; Salvado O; Villemagne VL; Rowe CC;
Neuroimage; 2018 Dec; 183():387-393. PubMed ID: 30130643
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of semi-quantitative measures of
Müller EG; Stokke C; Stokmo HL; Edwin TH; Knapskog AB; Revheim ME
Quant Imaging Med Surg; 2022 Jan; 12(1):493-509. PubMed ID: 34993096
[TBL] [Abstract][Full Text] [Related]
7. A new Centiloid method for
Cho SH; Choe YS; Kim HJ; Jang H; Kim Y; Kim SE; Kim SJ; Kim JP; Jung YH; Kim BC; Baker SL; Lockhart SN; Na DL; Park S; Seo SW
Eur J Nucl Med Mol Imaging; 2020 Jul; 47(8):1938-1948. PubMed ID: 31834446
[TBL] [Abstract][Full Text] [Related]
8. Software development for quantitative analysis of brain amyloid PET.
Matsuda H; Yamao T
Brain Behav; 2022 Mar; 12(3):e2499. PubMed ID: 35134278
[TBL] [Abstract][Full Text] [Related]
9. Expression of regional brain amyloid-β deposition with
Bao YW; Wang ZJ; Guo LL; Bai GJ; Feng Y; Zhao GD
Neuroradiology; 2024 Apr; ():. PubMed ID: 38676749
[TBL] [Abstract][Full Text] [Related]
10. Automated semi-quantitative amyloid PET analysis technique without MR images for Alzheimer's disease.
Imabayashi E; Tamamura N; Yamaguchi Y; Kamitaka Y; Sakata M; Ishii K
Ann Nucl Med; 2022 Oct; 36(10):865-875. PubMed ID: 35821311
[TBL] [Abstract][Full Text] [Related]
11. Quantitative Evaluation of
Matsuda H; Ito K; Ishii K; Shimosegawa E; Okazawa H; Mishina M; Mizumura S; Ishii K; Okita K; Shigemoto Y; Kato T; Takenaka A; Kaida H; Hanaoka K; Matsunaga K; Hatazawa J; Ikawa M; Tsujikawa T; Morooka M; Ishibashi K; Kameyama M; Yamao T; Miwa K; Ogawa M; Sato N
Front Neurol; 2020; 11():578753. PubMed ID: 33519667
[No Abstract] [Full Text] [Related]
12. Centiloid scale analysis for
Yamao T; Miwa K; Wagatsuma K; Shigemoto Y; Sato N; Akamatsu G; Ito H; Matsuda H
Phys Med; 2021 Feb; 82():249-254. PubMed ID: 33677386
[TBL] [Abstract][Full Text] [Related]
13. A universal neocortical mask for Centiloid quantification.
Bourgeat P; Doré V; Rowe CC; Benzinger T; Tosun D; Goyal MS; LaMontagne P; Jin L; Weiner MW; Masters CL; Fripp J; Villemagne VL; ;
Alzheimers Dement (Amst); 2023; 15(3):e12457. PubMed ID: 37492802
[TBL] [Abstract][Full Text] [Related]
14. Non-negative matrix factorisation improves Centiloid robustness in longitudinal studies.
Bourgeat P; Doré V; Doecke J; Ames D; Masters CL; Rowe CC; Fripp J; Villemagne VL;
Neuroimage; 2021 Feb; 226():117593. PubMed ID: 33248259
[TBL] [Abstract][Full Text] [Related]
15. β-amyloid PET harmonisation across longitudinal studies: Application to AIBL, ADNI and OASIS3.
Bourgeat P; Doré V; Burnham SC; Benzinger T; Tosun D; Li S; Goyal M; LaMontagne P; Jin L; Rowe CC; Weiner MW; Morris JC; Masters CL; Fripp J; Villemagne VL;
Neuroimage; 2022 Nov; 262():119527. PubMed ID: 35917917
[TBL] [Abstract][Full Text] [Related]
16. Longitudinal Assessment of Amyloid-β Deposition by [18F]-Flutemetamol PET Imaging Compared With [11C]-PIB Across the Spectrum of Alzheimer's Disease.
Hatashita S; Wakebe D; Kikuchi Y; Ichijo A
Front Aging Neurosci; 2019; 11():251. PubMed ID: 31572167
[TBL] [Abstract][Full Text] [Related]
17. Comparison of [
Lowe VJ; Lundt E; Knopman D; Senjem ML; Gunter JL; Schwarz CG; Kemp BJ; Jack CR; Petersen RC
Neuroimage Clin; 2017; 16():295-302. PubMed ID: 28856092
[TBL] [Abstract][Full Text] [Related]
18. Implementation and validation of an adaptive template registration method for 18F-flutemetamol imaging data.
Lundqvist R; Lilja J; Thomas BA; Lötjönen J; Villemagne VL; Rowe CC; Thurfjell L
J Nucl Med; 2013 Aug; 54(8):1472-8. PubMed ID: 23740104
[TBL] [Abstract][Full Text] [Related]
19. Defining a Centiloid scale threshold predicting long-term progression to dementia in patients attending the memory clinic: an [
Hanseeuw BJ; Malotaux V; Dricot L; Quenon L; Sznajer Y; Cerman J; Woodard JL; Buckley C; Farrar G; Ivanoiu A; Lhommel R
Eur J Nucl Med Mol Imaging; 2021 Jan; 48(1):302-310. PubMed ID: 32601802
[TBL] [Abstract][Full Text] [Related]
20. Differential centiloid scale normalization techniques: comparison between hybrid PET/MRI and independently acquired MRI.
Yamakuni R; Murakami T; Ukon N; Kakamu T; Toda W; Hattori K; Sekino H; Ishii S; Fukushima K; Matsuda H; Ugawa Y; Wakasugi N; Abe M; Ito H
Ann Nucl Med; 2024 Jun; ():. PubMed ID: 38902587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
